The 1st double blind RCT, addressing the need for more high-quality evidence to guide dressing selection. The double blind randomised controlled trial CHALLENGE is a unique “first” for dressings…never before has a foam dressing ever demonstrated a superior efficacy. The CHALLENGE RCT is the largest study of this kind which has been undertaken in wound care. 187 patients were recruited in record time, bearing testament to the interest in this study shown by the 45 hospital investigator sites which took part in the study.
URGOSTART®, a range of fantastic products, a study with a sound methodology that impressed UK KOLs, and results which are even beyond our wildest expectations.
You can discover more about the CHALLENGE study on this link.
Soft-adherent foam dressing made of a TLC layer (Technology Lipido-Colloid) with healing accelerator (NOSF Nano-OligoSaccharide Factor), a unique compound to rebalance wound equilibrium and neutralise proteases in order to:
promote faster healing, saving nursing time
improve patient's quality of life: less pain, less trauma